Sinopharm
1099.HK
#2137
Rank
โ‚ฌ6.18 B
Marketcap
1,98ย โ‚ฌ
Share price
-2.02%
Change (1 day)
-20.55%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚ฌ59.51 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚ฌ74.14 Billion. an increase over the revenue in the year 2022 that were of โ‚ฌ70.33 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 โ‚ฌ74.14 B5.42%
2022 โ‚ฌ70.33 B-2.1%
2021โ‚ฌ71.83 B16.85%
2020โ‚ฌ61.47 B14.95%
2019โ‚ฌ53.48 B21.52%
2018โ‚ฌ44.01 B5.93%
2017โ‚ฌ41.54 B27.22%
2016โ‚ฌ32.65 B5.37%
2015โ‚ฌ30.99 B9.14%
2014โ‚ฌ28.39 B17.22%
2013โ‚ฌ24.22 B25.94%
2012โ‚ฌ19.23 B34.61%
2011โ‚ฌ14.28 B55.34%
2010โ‚ฌ9.19 B35.79%
2009โ‚ฌ6.77 B37.56%
2008โ‚ฌ4.92 B31.43%
2007โ‚ฌ3.74 B40.26%
2006โ‚ฌ2.67 B